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The mRNA cap recruits factors essential for tran-
script processing and translation initiation.We report
that regulated mRNA cap methylation is a feature of
embryonic stem cell (ESC) differentiation. Expres-
sion of the mRNA cap methyltransferase activating
subunit RAM is elevated in ESCs, resulting in high
levels of mRNA cap methylation and expression of
a cohort of pluripotency-associated genes. During
neural differentiation, RAM is suppressed, resulting
in repression of pluripotency-associated factors
and expression of a cohort of neural-associated
genes. An established requirement of differentiation
is increased ERK1/2 activity, which suppresses plu-
ripotency-associated genes. During differentiation,
ERK1/2 phosphorylates RAM serine-36, targeting
it for ubiquitination and proteasomal degradation,
ultimately resulting in changes in gene expression
associated with loss of pluripotency. Elevated RAM
expression also increases the efficiency of fibroblast
reprogramming. Thus, the mRNA cap emerges as
a dynamic mark that instructs change in gene
expression profiles during differentiation and reprog-
ramming.INTRODUCTION
In pluripotent stem cells, differential expression of a network of
transcription factors governs the selection of self-renewal or dif-
ferentiation (Dunn et al., 2014; Tanabe et al., 2014). A stable
pluripotent state can be induced in somatic cells by expression
of four transcription factors: Oct4, Sox2, Klf4, and c-Myc (Taka-
hashi et al., 2007; Takahashi and Yamanaka, 2006). Chromatin1352 Cell Reports 16, 1352–1365, August 2, 2016 ª 2016 The Author
This is an open access article under the CC BY license (http://creativemodifiers and remodelers and the transcriptional machinery
facilitate the function of the core transcription factors during dif-
ferentiation and reprogramming (Bickmore and Zaret, 2010).
However, changes in transcription alone cannot achieve the pro-
teomic requirements of pluripotency and differentiation. Notably,
an initial study that generated induced pluripotent stem cells
required enhanced expression of LIN28, which promotes trans-
lation by antagonizing Let7microRNA (miRNA) function (Yu et al.,
2007). Influential RNA regulons that drive changes in the trans-
lational profile during differentiation and reprogramming can
be coordinated by RNA modifications, RNA binding proteins,
miRNAs, or the translation machinery (Jia et al., 2012; Stunnen-
berg et al., 2015; Tahmasebi et al., 2014; Wang et al., 2013;
Wong et al., 2016).
During transcription, pre-mRNA receives a series of modifica-
tions to create the 50 mRNA cap that protects nascent transcripts
from exonucleases and forms a recruitment platform for cap-
binding complexes, which mediate gene expression mecha-
nisms, including RNA splicing, nuclear export, and translation
initiation (Gonatopoulos-Pournatzis and Cowling, 2014a; Shu-
man, 2015; Topisirovic et al., 2011). The basic mRNA cap struc-
ture (cap 0) is 7-methylguanosine linked via triphosphate to the
first transcribed nucleotide (X), m7G(50)ppp(50)X. Cap formation
is catalyzed by a series of enzymes (Topisirovic et al., 2011). In
mammals, RNGTT has triphosphatase and guanylyltransferase
activities that add the guanosine cap to the nascent transcript.
Subsequently, the guanosine cap is methylated on the N-7 posi-
tion by RNMT-RAM, creating the mature cap 0 structure. RNMT-
RAM is critical for gene expression, since the completion of cap
0 renders transcripts competent to be processed and translated.
The mammalian cap methyltransferase consists of a catalytic
subunit, RNMT (RNA guanine-7 methyltransferase), and an
activating subunit, RAM (RNMT-activating miniprotein) (Gonato-
poulos-Pournatzis et al., 2011; Topisirovic et al., 2011). RNMT
has basal methyltransferase activity, which RAM increases 5-
to 10-fold. RNMT and RAM also stabilize each other and have
only been isolated as a complex. RAM consists an N-terminals.
commons.org/licenses/by/4.0/).
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activation domain, a central RNA binding domain that increases
RNA recruitment, and a C-terminal nuclear localization domain
(Gonatopoulos-Pournatzis and Cowling, 2014b). RNMT-RAM is
recruited to phosphorylated RNA pol II, coordinating capping
with the initiation of transcription (Aregger and Cowling, 2013;
Glover-Cutter et al., 2008). Both RNMT and RAM expression
was found to be required for gene expression, cell proliferation,
and viability (Chu and Shatkin, 2008; Gonatopoulos-Pournatzis
et al., 2011).
Formation of themRNA cap is incomplete on certain transcripts
and regulated by cellular signaling pathways (Cole and Cowling,
2009; Cowling and Cole, 2007; Fernandez-Sanchez et al., 2009;
Jiaoet al., 2010, 2013;Mukherjeeet al., 2012). Inyeast, incomplete
mRNA caps are associated with RNA degradation, whereas in
mammals, transcripts with incomplete caps can be stable but
translated at a vastly reduced rate (Cowling and Cole, 2007; Fer-
nandez-Sanchez et al., 2009;Mukherjee et al., 2012). CDK1 phos-
phorylates and activates RNMT, coordinating G1 transcription
with mRNA cap methylation (Aregger et al., 2016). The transcrip-
tion factors c-Myc and E2F-1 upregulate RNA pol II phosphoryla-
tion,which increasesRNMT-RAMrecruitment to transcription initi-
ation sites and stimulates mRNA cap formation (Aregger and
Cowling, 2012; Cole and Cowling, 2009; Cowling and Cole,
2007). c-Myc-dependent mRNA cap methylation is also depen-
dent on upregulation of SAHH, the enzyme that hydrolyses the
inhibitory byproduct of methylation (Fernandez-Sanchez et al.,
2009).
Here, we report that RNMT-RAM is regulated during embry-
onic stem cell (ESC) differentiation and fibroblast reprogram-
ming. Expression of a cohort of pluripotency-associated genes
is dependent on high levels of the cap methyltransferase acti-
vator RAM, present in embryonic or induced pluripotent stem
cells. During differentiation, ERK1/2-dependent phosphorylation
triggers RAM degradation, resulting in repression of pluripo-
tency-associated genes and expression of differentiation-asso-
ciated genes.
RESULTS
RNMT and RAM Are Differentially Expressed in Primary
Tissues
The expression of the mRNA cap methyltransferase RNMT and
its activator, RAM, was investigated in a panel of mouse organs
and ESCs (Figure 1A). RNMT and RAM expression varied across
the panel, with the highest expression of RNMT in brain, spleen,
and testis and the highest expression of RAM in heart, lung, and
liver. At extremes, brain tissue had significant RNMT expression
but minimal RAM expression, whereas heart tissue had minimal
RNMT expression but significant RAM expression. For thisFigure 1. Expression of RAM Is Suppressed during Murine Neural Diffe
(A) Mouse organ and murine ESC extracts analyzed by western blot (WB). Ponce
(B) ESCs, primary cortical neurons, and primary astrocytes extracts analyzed by
(C) Phase-contrast images of cultures. Scale bar, 100 mm.
(D) Proteins, including Sox1 (GFP reporter), were detected by immunofluorescen
(E) Proteins detected by WB.
(F) Transcripts detected by RT-PCR, normalized to Actin. Data represent an ave
See also Figures S1–S3.
1354 Cell Reports 16, 1352–1365, August 2, 2016analysis, polyclonal antibodies raised against full-length RNMT
and RAM that recognize epitopes across the proteins were
used, and therefore, loss of signal is likely due to loss of protein
and not post-translational modification or specific isoform
expression (Aregger and Cowling, 2013; Gonatopoulos-Pour-
natzis and Cowling, 2014b). The observations made with the
organ panel imply that different cell lineages will contain different
RNMT to RAM ratios. Since brain tissue exhibited a high RNMT
to RAM ratio, these proteins were analyzed in primary neural
cells. In murine primary cortical neurons, the RNMT level was
equivalent to that in ESCs, whereas the RAM level was reduced
(Figure 1B). In astrocytes, RNMT and RAM expression was min-
imal compared to ESCs.
RAM Expression Is Reduced during Neural
Differentiation
Since RAM activates RNMT, reduced RAM expression was pre-
dicted to have consequences for mRNA cap formation and
gene expression. We utilized an ESC differentiation protocol to
investigate RAM function during neural differentiation (Figures
1C–1F, S1A, S1B, and S2A) (Wongpaiboonwattana and Stavridis,
2015; Ying et al., 2003). During this protocol, the emergence of
neural morphology; loss of ESC pluripotency factors Oct4, Klf4,
Sox2, and Nanog; and gain of neural markers Nestin, Sox1
(observed by GFP Sox1 locus knockin, Sox1Gt(EGFP)Asmi), and
Pax6 confirmed differentiation into neural precursors (Aubert
et al., 2003).Duringdifferentiation, the reduction inKlf4andNanog
protein levels reflected changes in transcript levels, implying
predominantly transcriptional control of these genes (Figures
1E, 1F, and S2A). However, Oct4 and Sox2 protein levels were
maintained from day 1 to 5/6 of differentiation, despite transcript
levels falling significantly during this period (Figures 1E and 1F).
This implies significant post-transcriptional control of Oct4 and
Sox2 during the initial days of differentiation, maintenance of
Oct4 and Sox2 translation rates, and/or inhibition of protein
degradation.
During neural differentiation, RNMT protein levels decreased
slightly, whereas RAM protein levels decreased significantly by
day 5 (Figures 1E and S2A), resulting in a high RNMT to RAM ra-
tio, which was also observed in brain tissue and cortical neurons
(Figures 1A and 1B). RAM transcript levels were maintained
during neural differentiation, and therefore, RAM protein is
reduced by a post-transcriptional mechanism (Figure 1F). Similar
reductions in RNMT and RAM expression were observed during
differentiation of human SA181 ESCs into neural precursors
(Figure S3) (Chambers et al., 2009). Loss of SOX2 and OCT4
expression, gain of PAX6 and bIII-tubulin, and the appearance
of neurites indicated loss of pluripotency and induction of the
neural phenotype (Figures S3A–S3C). During differentiation,rentiation
au S was used to stain PVDF membranes.
WB. ESCs were cultured according to a 9-day neural differentiation protocol.
ce (IF). Scale bar, 10 mM. DAPI DNA stain was used.
rage of three independent experiments, and error bars indicate SD.
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Figure 2. RAM Is Important for Oct4, Sox2, and
Klf4 Expression
(A) ESCs transfected with three independent siRNAs,
pool, or a non-targeting control for 48 hr.
(B) RNA-protein complexes resolved through sucrose
gradient. RNA was purified and quantitated. Mean and
SEM of four independent experiments are presented.
(C) Relative ratio of monosomes to polysomes.
(D) ESCs infected with lentiviruses carrying RAM or
control small hairpin RNAs (shRNAs), seeded at
clonal density, and stained for alkaline phosphatase
(AP) after 7 days. Over 290 colonies were scored
in three independent experiments, and average
percent AP positive, mixed, or negative colonies are
reported.
(E) ESCs were transfected with RAM or control siRNA
for 48 hr and fixed, and proteins were detected by IF.
Scale bar, 10 mm.
(F) Quantitation of average cellular staining in five in-
dependent fields (ImageJ software). Data are repre-
sentative of two independent experiments.
(G) For at least three independent experiments,
average protein level relative to actin was detected by
WB and quantitated.
(H) Anti-m7G antibodies or matched controls used to
immunoprecipitate m7G-RNA (RT-PCR analysis).
(C, D, G, and H) Error bars indicate SD for at least three
independent experiments. t test p value relative to
control (*p < 0.05; **p < 0.01, ***p < 0.001).
See also Figure S4.RNMT expression reduced slightly whereas RAM expression
was minimal by day 7 (Figure S3B). As in murine ESC differenti-
ation, a reduction in RAM transcripts did not accompany loss of
RAM protein, which is therefore repressed by a post-transcrip-
tional mechanism (Figure S3C).
In order to understand the consequences of reduced RAM
expression, it was important to determine whether in ESCs RAM
functions only in a complex with RNMT or also functions as a
monomer or in other complexes. In previously investigated cell
lines, RAMwas only observed in a complex with RNMT (Gonato-
poulos-Pournatzis et al., 2011). In ESCs, RAM monomers were
not detected by gel filtration (Figure S2B). Using reciprocal immu-
noprecipitations (IPs), RNMT and RAM were found in a complex
(Figure S2C). RNMT IP significantly depleted RAM from cell ex-
tracts, whereas RAM IP only partially depleted RNMT, consistent
with the majority of RAM being complexed with RNMT. A likely
scenario is that during differentiation, RNMT-RAM complexes
decrease and RNMT monomers increase. Consistent with aCereduction in RAM, day 5 neural precursors ex-
hibited reducedcapmethyltransferase activity
compared to day 4 (Figure S2D).
RAM Is Important formRNATranslation
and Oct4, Sox2, and Klf4 Expression
We investigated whether the high RAM levels
in ESCs have biological significance. RAM
expression was reduced by small interfering
RNA (siRNA) transfection, reproducing theminimal expression observed in neural cells (Figure 2A). Since
the mRNA cap and mRNA cap methyltransferase can affect
mRNA transcription, stability, processing, export, and transla-
tion initiation, the effect of RAM reduction on the net output of
these events, the translational profile, was investigated. Equiva-
lent numbers of ESCs were plated and transfected with RAM
siRNA or control, and 48 hr, later native RNA-protein complexes
were separated by centrifugation through a sucrose gradient and
detected by UV absorbance (Figure S4A). The experiment was
performed on four independent occasions, and the RNA content
of fractions was quantitated (Figures 2B and S4B). Free ribo-
somes and ribosomal subunits (monosomes) were separated
from translating RNA-ribosome complexes (polysomes).
Reduced RAM expression resulted in a significant reduction in
the ratio of polysomes to monosomes, indicating reduced ribo-
some loading of mRNA and a translation defect (Figure 2C).
Note that transfection of RAM siRNA in this experimental proto-
col resulted in a small reduction in cell number after 2 daysll Reports 16, 1352–1365, August 2, 2016 1355
(14.3%, 4.3%SD), accounting for the reduced monosome peak
in RAM siRNA-treated cells (Figure S4C).
We investigated the biological impact of RAM on ESCs.
Alkaline phosphatase staining can be used as a marker of plurip-
otency (Martı´ et al., 2013). On plating ESCs at clonal density, in-
hibition of RAM resulted in a significant decrease in alkaline
phosphatase-positive colonies and an increase in mixed and
negative colonies (Figures 2D, S4D, and S4E). Immunofluores-
cence (IF) analysis indicated that suppression of RAM resulted
in reduced expression of the pluripotency-associated transcrip-
tion factors Sox2 and Oct4, whereas Nanog expression was
minimally repressed (Figures 2E and 2F). Western blot analysis
of cell extracts confirmed significant repression of Sox2 and
Oct4, but not Nanog, protein expression in multiple indepen-
dent experiments (Figure 2G). Another pluripotency-associated
transcription factor, Klf4, was also significantly repressed in
response to RAM suppression.
Oct4, Sox2, andKlf4maybedirectly or indirectly dependent on
RAM for expression. We confirmed that reduced RAM expres-
sion results in loss of cap methylation of Oct4, Sox2, and Klf4
transcripts (Figure 2H). The proportion of transcripts with an
m7G cap is detected by a semiquantitative method in which
m7G-RNA is subject to IP and transcripts detected by RT-PCR
(Nanog was not amenable to this technique, potentially due to
secondary structure) (Cole and Cowling, 2009). These data indi-
cate that Oct4, Sox2, and Klf4 are likely to be direct targets of
RNMT-RAM-dependent cap methylation. However, the depen-
dency of transcripts on them7G-cap for expression, processing,
and translation is gene specific. Therefore, we performed an un-
biased analysis of RAM-dependent genes, investigating tran-
script expression, polysome loading, and protein expression.
RAM Regulates the Expression of Transcripts
Associated with Pluripotency
In order to comprehensively identify RAM-dependent genes, we
performed a RNA-sequencing (RNA-seq) transcriptome analysis
of ESCs transfected with RAM siRNA or control in four biological
replicates (Figure S4B). In response to RAM suppression, from
12,803 genes that passed quality thresholds, 2,398 genes
were downregulated and 2,569 upregulated (p value < 0.05) (Fig-
ure 3A; Table S1). A series of unbiased analyses were performed
to determine whether these genes have related biological func-
tions. GeneOntology (GO) analysis of RAM-regulated transcripts
determined that genes associated with developmental pro-
cesses were among the most significantly enriched (Figure 3B).
Gene set enrichment analysis revealed that RAMsuppression re-
sulted in significant repression of a set of genes previously impli-
cated in ESC function (p value = 0.002) (Boroviak et al., 2015;
Chen et al., 2008; Dunn et al., 2014; Kim et al., 2008) (Figures
3C and S5). Suppression of components of the TFIID and
Paf1 complexes, which mediate pluripotency-associated gene
expression (Pijnappel et al., 2013; Ponnusamy et al., 2009),
and the INO80 complex, which maintains open chromatin at
pluripotency gene promoters, were also RAM regulated (Wang
et al., 2014) (Figures 3C and S5). Statistically significant repres-
sion of Oct4, Klf4, and Nanog transcripts was observed.
Since RAM is reduced during neural differentiation, the contri-
bution of RAM to gene expression changes concomitant with1356 Cell Reports 16, 1352–1365, August 2, 2016this process was investigated. Previously established ESC and
neural-specific gene sets were analyzed (see Supplemental
Experimental Procedures). On RAM suppression, all established
ESC-specific gene sets testedwere significantly downregulated,
and all established neuronal-specific gene sets tested were
significantly upregulated, including genes activated during
N2B27 neural differentiation (Figures 3D and 3E). Thus, high
levels of RAM in ESCs are important for the expression of plurip-
otency-associated genes, and its repression contributes to the
upregulation of neural-specific genes.
In order to ascertain the specificity that RAM imparts on RNA
translation, the transcript content of polysomes was analyzed in
response to RAM suppression (Figure 2B). Out of 12,803 genes
analyzed, only 26 genes exhibited RAM-dependent changes in
polysome loading normalized to input transcripts (Figure 3F;
Table S1). Therefore, RAM does not exhibit specificity over
translational control and globally promotes ribosome loading.
Since suppression of RAM results in differential changes
in transcript level and global changes in polysome loading,
we investigated the resultant effect on the cellular proteome.
A proteomic analysis of ESCs transfected with RAM siRNA in
three biological replicates was performed using liquid chro-
matography-tandem mass spectrometry (LC-MS/MS) (Figures
S6A and S6B). Proteins were identified and quantified using
Maxquant software (Cox and Mann, 2008) (Table S2). Global
proteomics studies have the caveat of identifying themost abun-
dant and usually the most stable proteins; however, from the
2,617 proteins that passed quality thresholds, 59 were downre-
gulated and 38 upregulated (p value FDR % 0.05) (Figure S6C;
Table S3). GO term analysis revealed that downregulated genes
were enriched in categories including ‘‘gene expression,’’ ‘‘RNA
processing,’’ and ‘‘translation’’ (Table S4; Figure S6D). Of note,
the translation factors EIF4G1, EIF4G2, EIF3J1, and EIF6;
ribosomal proteins RPL13a, RPL9, and RPS16; and tRNA syn-
thetases WARS, CARS, and LARS were all found to be RAM
regulated, which is likely to contribute to the global defects
in translation (Figure S7). The group of proteins significantly
repressed in response to RAM suppression was significantly
repressed at the transcript levels, indicating transcript-level con-
trol of these genes (p value = 0.01) (Figure 3G; Table S5).
Repression of RAM Is Important for Neural
Differentiation
In ESCs, high levels of RAM are important for the expression
of pluripotency-associated genes and suppression of RAM in-
duces neural-associated genes. In order to determine whether
the repression of RAM observed during neural differentiation
contributes to this process, ESCs were engineered to constitu-
tively express RAM-GFP from a plasmid under the control of a
chimeric promoter (Figures 4A, 4B, and S8A). These cells were
morphologically indistinct from control ESCs (Figure 4A). During
neural differentiation, RAM-GFP and endogenous RAM expres-
sion was maintained (Figure 4B). RAM-GFP-expressing cells
exhibited some features associated with neural differentiation
(Figure 4A) and increased Nestin transcripts (Figure S8B).
During neural differentiation of ESC:RAM-GFP, the decrease in
Klf4 protein expression was equivalent to that observed in ESCs
(Figure 4B). However, expression of the pluripotency markers
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Figure 4. Sustained RAM Expression Main-
tains Pluripotency Markers during Differen-
tiation
(A) ESC:RAM-GFP or control cultured in a 9-day
neural differentiation protocol. Phase-contrast im-
ages are shown. Scale bar, 100 mm.
(B) Protein detected by WB.
(C) Oct4 and Sox2 protein level quantitated in
three independent experiments. Mean and SD are
presented.
(D) Oct4 and tubulin III detected by IF.
See also Figure S8.Oct4 and Sox2was partially maintained in ESC:RAM-GFP during
differentiation, whereas in control cells, their expression is
repressed by day 6 (Figures 1, 4B, and S2A). Quantitation of
four independent experiments revealed that Oct4 and Sox2
expression decreases during the initial days of differentiation;
however, later during differentiation (days 5–9), Oct4 and Sox2
expression plateaus (Figure 4C). IF analysis indicated that
preventing RAM repression delayed and impaired differentia-
tion (Figure 4D). During differentiation of control ESCs, Oct4(D) RAM siRNA-induced directional transcript changes for ESC- or neural-specific gene sets (see Experim
(E) Boxplot representation of (D). p values (false discovery rate [FDR]) are log10 transformed and shown belo
respectively.
(F) Scatterplot of expression changes at transcript and polysome level.
(G) Boxplot of transcript changes of proteins unchanged (unsig.), downregulated, or upregulated in mas
performed with ROAST (see Experimental Procedures). **p < 0.01, ***p < 0.001. Boxplot whiskers span fro
See also Figures S5–S7.
1358 Cell Reports 16, 1352–1365, August 2, 2016expression was minimal by day 6, and
expression of the neural marker tubulin III
was observed in neurites on day 9.
In ESC:RAM-GFP, Oct4 expression was
distinct on day 6 and detectable on day 9,
and tubulin III was visible on day 9 but
less extensive compared to that seen in
control cells.
RAM Expression Is Dependent on
Oct4 and Sox2
Since RAM controls gene expression in
ESCs and during neural differentiation, we
investigated the mechanisms that regulate
its expression. Initial investigation focused
on the pluripotency-associated transcrip-
tion factors Oct4, Sox2, Klf4, and Nanog
(Figures 5A–5C). Inhibition of Oct4 and
Sox2 expression by single or siRNA pool
transfection resulted in a reduction in
RAM protein expression, whereas inhibi-
tion of Klf4 and Nanog did not. Consistent
with previous studies, transfection of Oct4
or Sox2 siRNA reduced expression of Klf4
and Nanog (Figure 5A) (Dunn et al., 2014).
It is possible that RAM is repressed in
response to severe disruption of this tran-scriptional network rather than specifically in response to Oct4
and Sox2 inhibition. Regulation of RAM expression did not
appear directly transcriptional; suppression of Sox2 and Oct4
did not result in RAM transcript loss (Figure S9), and RAM tran-
script loss did not accompany RAM protein loss during neural
differentiation (Figure 1F). Characterization of RAM regulation
focused on Sox2 rather than Oct4, since inhibition of later results
in overt toxicity. The reduction in RAM expression resulting from
Sox2 suppression was reversed by addition of a proteasomeental Procedures for a sets description).
w or above axis for down- or upregulated gene sets,
s spectrometry analysis (Figure S6). Gene set tests
m the 5th to 95th percentiles.
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Figure 5. RAM Is Ubiqutinated and Degraded
by the Proteasome
(A–C) Expression of Oct4, Sox2, Klf4, and Nanog
inhibited by transfection of siRNA pools (A) or in-
dependent siRNAs (B andC) for 72 hr. Proteins were
detected by WB.
(D) ESCs were transfected with Sox2 siRNA for
72 hr, then 1, 2, or 5 mM MG132 was added for the
time indicated. WB analysis is shown. LE indicates
long exposure, and the asterisk (*) indicates high-
molecular-weight protein.
(E) ESCs subject to neural differentiation. On day 6,
cells were treated with 2 mM MG132 or DMSO
control for 3 hr.
(F) Neural differentiation on day 7. Immunoprecipi-
tations were performed on cell extracts using anti-
RAM or control antibodies. Asterisk (*) indicates
high-molecular-weight ubiquitinated proteins de-
tected by WB. LC, light chain; HC, heavy chain.
(G) ESCs expressing 6His-ubiqutin (6His-Ubq) or
control (c) incubated in 2 or 5 mM MG132 for 4 hr.
Extracts subject to Ni-NTA agarose pull-down
and WB.
(H) ESC:Fg-RAM or RAM-GFP transfected with
Sox2 siRNA for 72 hr. Fg-RAM and RAM-GFP were
purified via tags. RAM and high-molecular-weight
ubiquitinated protein was detected by WB.
(I) As in (H), except Fg-RAM WT and 3K were
expressed.
See also Figure S9.inhibitor MG132 (Figure 5D). Treatment with MG132 resulted in
high molecular weight smear visible in the RAM western blot,
consistent with an unstable pool of modified RAM. Furthermore,
loss of RAM during neural differentiation was rescued by treat-
ment with MG132, accompanied by high-molecular-weight
RAM protein (Figure 5E).
Since covalent linkage of ubiquitin can mark proteins for
degradation, we investigated whether RAM is ubiquitinated
prior to degradation. RAM IPs from day 7 neural precursors
included high-molecular-weight ubiquitinated protein, which
increased following proteasome inhibition, consistent with
an unstable pool of RAM-ubiquitin (Figure 5F). RAM was
confirmed to be ubiquitinated by purification in denaturing
conditions covalently linked to 6His-ubiquitin via nickel-
charged resin (Figure 5G). When Sox2 expression was in-
hibited by siRNA transfection, RAM ubiquitination increased
(Figure 5H). This result was observed with Fg-RAM and
RAM-GFP, which were transfected and purified via their tags.
Since ubiquitin conjugates to lysine residues, point mutations
were made to map ubiquitination sites (K10N, K24R, andCell RK31R; RAM 3K). K to R mutations are
usually made to inhibit ubiquitination,
but the K10N mutation was used, since
this is a SNP. RAM 3K exhibited reduced
ubiquitination, consistent with ubiquitin
being conjugated to one or more of the
mutated lysine residues (Figure 5I). Map-
ping RAM ubiquitination using single K
mutants was attempted. However, someof these mutants were toxic and poorly expressed, precluding
robust conclusions being drawn.
ERK1/2 Phosphorylation of RAM S36 Promotes
Ubiquitination
We characterized the signaling pathways that trigger RAM ubiqui-
tination and degradation during differentiation. We observed that
RAM is phosphorylated on serine 36 (S36) and investigated the
impact of this modification on ubiquitination and degradation.
ESC lines were created expressing Fg-RAM WT and S36A to
ablate phosphorylation. Basal levels of Fg-RAM WT and S36A-
ubiquitination were detected in untreated controls (Figure 6A).
OnMG132 treatment, Fg-RAMWTand S36A-ubiquitin increased,
indicating that these ubiquitin conjugatesaredegradedby thepro-
teasome in ESCs. Despite being expressed equivalently, Fg-RAM
S36Aexhibited reducedubiquitinationcompared toWT, indicating
that S36 phosphorylation is important (albeit not essential) for this
modification. Note that the DMSO used as a vehicle control re-
ducesbasalRAMubiquitination, the reasons forwhichareunclear,
but DMSO is routinely observed to influence enzyme function.eports 16, 1352–1365, August 2, 2016 1359
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(A) Fg-RAM WT or S36A purified from ESCs treated
with 5 mM MG132, DMSO control, or untreated for
3 hr. RAMandubiquitinated protein detected byWB.
(B) RAM-GFP WT and S36A and GFP alone (puri-
fied) and WBs were performed to detect pS36 RAM
and total RAM.
(C) ESC extracts treated with lambda phosphatase
for the time indicated, and pS36 RAM and total
RAM were detected.
(D) ESCs subjected to neural differentiation proto-
col. Extracts were analyzed by WB on the days
indicated.
(E) Fg-RAM WT and S36A expressed in ESCs.
ESCs and day 6 neural precursors, pre-treated with
2 mM MG132 or DMSO control for 3 hr, were
analyzed by WB.
(F) As in (E), except expression of Oct4, Nanog, and
Sox2 was analyzed in day 5 neural precursors.
(G) Expression of pERK1/2 and ERK1/2 analyzed by
WB during neural differentiation.
(H) 50 ng ERK2 incubated with 1 mg GST-RAM WT
or S36A and 32PATP for 1 hr at 37C. Phosphory-
lated protein was detected by film. GST-RAM was
visualized by Coomassie staining.
(I) 10 ng GST-RAM subject to in vitro kinase assay
with ERK2 or control analyzed by WB.
(J) Day 5 neurodifferentiated cells treated with 1 mM
PD0325901 for the time indicated and proteins
detected by WB.
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for 72 hr and treated with 1mMPD0325901or DMSO
for 12 hr. Extracts were analyzed by WB.
(L) As in (K), except cells were treated with 2 mM
MG132 for 2 hr prior to WB analysis. Top: RAM was
immunoprecipitated and ubiquitin detected.
See also Figure S10.In order to characterize RAMS36 phosphorylation, an antibody
was raised against pS36, a RAM peptide phosphorylated on
serine 36. The pS36 RAM antibody was phospho-specific, since
it detected RAM-GFP wild-type (WT) and not S36A (Figure 6B),
and the signal for endogenous RAM diminished following phos-
phatase treatment (Figure 6C). Since S36 is important for RAM
ubiquitination, we investigated if RAM pS36 levels alter during
neural differentiation. RAM pS36 was at the limit of detection until
day 5, after which it was present, coincident with reduced total
RAM levels (Figures 6DandS2A). Since theS36Amutation results
in decreasedRAMubiquitination, its effect on protein stabilization
during differentiation was investigated. Expression of Fg-RAM
S36A was equivalently to that observed in WT ESCs (Figure 6E).
However, on day 6 of neural differentiation, Fg-RAMWT expres-
sion was reduced and partially rescued by proteasome inhibition,
whereas RAM S36A was stable during differentiation (Figure 6E).
Consistent with the expression of the markers of pluripotency,
Oct4 and Sox2, being dependent on RAM, RAM S36A amelio-1360 Cell Reports 16, 1352–1365, August 2, 2016rated their repression during neural differ-
entiation (Figure 6F), similar to the effect of
RAM-GFP (Figure 4).RAM S36 lies in a potential recognition motif for several
kinases, including ERK1/2, on which we focused, since it sup-
presses pluripotent gene expression (Hamilton and Brickman,
2014; Ying et al., 2003). Consistent with previous observations,
active phospho-ERK1/2 peaked at day 5 during neural differen-
tiation, when RAM pS36 and RAM degradation was first
observed (Figure 6G) (Pickford et al., 2011). Recombinant ERK
2 phosphorylated recombinant RAM WT, but not RAM S36A,
directly in vitro (Figure 6H). The pS36 antibody was further
validated by the specific detection of ERK2-phosphorylated
RAM (Figure 6I). In ESCs, inhibition of ERK activation using
1 mM PD0325901 on day 5 of neural differentiation inhibited
RAM phosphorylation (Figure 6J). Sox2 inhibition resulted in
increased RAM S36 phosphorylation, decreased expression
(Figure 6K), and increased ubiquitination (Figure 6L), and
PD0325901 reversed these effects.
Other kinases predicted based on substrate motif to be poten-
tial RAMS36 kinases (JNK, CDK1-cyclin B, CDK2-cyclin A1, and
CDK3-cyclin E) did not detectably phosphorylate RAM in vitro
and are therefore unlikely to phosphorylate RAM in cells (Fig-
ure S10). However, since ERK1/2 activity is not maintained at
high levels during differentiation, other kinases may phosphory-
late RAM S36 at this time.
RNMT-RAM Upregulation Has a Role in Reprogramming
Since RAM is important for the expression of pluripotency-asso-
ciated genes in ESCs, we investigated whether induction of plu-
ripotency or ‘‘reprogramming’’ utilizes RAM. Initially, RNMT and
RAM expression in ESCs, MEFs (mouse embryonic fibroblasts),
and iPSCs (induced pluripotent stem cells) was compared.
Strain 129/Ola MEFs were transduced with vectors expressing
Oct4, Klf4, Sox2, and c-Myc (Woltjen et al., 2009). Reprog-
rammed colonies (iPSCs) became visible as tightly packed clus-
ters of embryonic stem-like cells, staining alkaline phosphatase
(AP) positive and expressing Oct4, Sox2, c-Myc, and Nanog
(Figures 7A, 7B, and 7D). In comparison to ESCs, MEFs con-
tained less RNMT and RAM, and reprogramming to iPSCs
restored expression of both (Figure 7B). The transcript level for
RNMT and RAM was lower in MEFs than in ESCs and iPSCs,
suggesting that a component of RNMT and RAM suppression
is at the transcript level (Figure 7D). The same trend was
observedwith strain C57/BL6MEFs and iPSCs (data not shown).
RNMT and RAM expression was also reduced in human fibro-
blasts (hFs) compared to human ESCs (hESCs) and restored in
human iPSCs (Figure 7C). As with MEFs, RNMT and RAM tran-
script level was reduced in human fibroblasts (Figure 7E).
We investigated the function of RNMT and RAM in MEF re-
programming. Reprogramming was induced by expression of
Oct4, Sox2, Klf4, and c-Myc, which resulted in increased
RAM expression after 5 days (Figure 7F). During reprogram-
ming, RAM or RNMT expression was increased by overexpres-
sion of RAM-GFP or HA-RNMT and RAM-GFP on day 3 or 4,
resulting in increased reprogramming efficiency (Figure 7G).
Conversely, inhibition of RAM or RNMT expression by transfec-
tion of siRNA resulted in a reduction in iPSC colony formation
(Figure 7H).
DISCUSSION
Differentiation of ESCs employs extensive coordinated regula-
tion of transcription, RNA processing, translation, and protein
modification to achieve the functional proteomes required of
each lineage (Dunn et al., 2014; Lu et al., 2009; Sampath
et al., 2008; Tanabe et al., 2014). The cap is a potent mRNA
modification with the potential to coordinate the expression
of large cohorts of genes. We report that regulation of the
mRNA cap methyltransferase RNMT-RAM makes a critical
contribution to the gene expression changes required of differ-
entiation and reprogramming. In vertebrates, the cap methyl-
transferase consists of RNMT, the enzymic subunit, and
RAM, the activator subunit. High levels of RAM are found in
ESCs, whereas in most murine organs, there is reduced or min-
imal expression. Focusing on the neural system, high levels of
RNMT are present in brain tissue, cortical neurons, and in-vitro-
differentiated neural progenitors, whereas there are minimal
levels of RAM.RAM Function in ESCs
We addressed the biological significance of high RAM expres-
sion and cap methyltransferase activity in ESCs. In ESCs,
20% of genes analyzed were dependent on RAM for expres-
sion at the transcript level, including core pluripotency tran-
scription factors, and pluripotency-associated transcriptional
regulators and chromatin remodelers. The mRNA cap protects
transcripts from degradation during transcription, and the cap
methyltransferases have been demonstrated to promote tran-
scription (Topisirovic et al., 2011). In addition, some transcript-
level control may be a result of the indirect effects of RAM on
transcriptional regulators.
In contrast to its specific effect on transcripts, in ESCs, RAM is
a non-specific, global activator of translation. In response to
RAM suppression, there was a significant loss of polysomal
transcripts, but sequencing analysis revealed remarkably little
selectivity to these genes. The mRNA cap binds to eIF4F, which
recruits the transcript to the ribosome. However, our proteomic
analysis revealed that RAM also regulates expression of transla-
tion factors, ribosomal subunits, and tRNA synthetases and thus
may also regulate global translation indirectly.
Oct4 and Sox2 are two transcription factors required for plu-
ripotency, and their repression is required for many programs
of differentiation. In this paper, we demonstrate that Oct4 and
Sox2 are RAM responsive. At the protein level, Oct4 and Sox2
are repressed in ESCs 2 days following transfection with RAM
siRNA, and they are maintained during neural differentiation if
RAM-GFP is expressed to prevent RAM repression. What is
the mechanism of Oct4 and Sox2 regulation by RAM? We
demonstrate that expression of Oct4 transcripts is dependent
on RAM. In addition, Oct4 protein has a relatively short half-
life, and therefore, although RAM inhibits polysome loading of
all transcripts equivalently, proteins with short half-life are likely
to be particularly responsive to translational inhibition (Buckley
et al., 2012). Oct4 and Sox2 are also likely to be indirectly in-
hibited by suppression of RAMduring differentiation. Repression
of RAM inhibits expression of a large cohort of pluripotency-
associated factors that may promote differentiation, repressing
Oct4 and Sox2 as part of the process.
Gene Specificity of RAM
RAM not only activates RNMT catalytic activity but also recruits
RNA to the methyltransferase via its RNA-binding domain. Prior
to this study, RAM was thought to be a constitutive factor pre-
sent on every RNMT protein, and therefore, whether the RNA
binding domain has sequence specificity was not at the forefront
of investigation (Gonatopoulos-Pournatzis et al., 2011). Now that
we recognize that there is a loss of RNMT-RAM heterodimers
and gain of RNMT without RAM (probably monomers) during dif-
ferentiation, the nature of RAM-RNAbinding specificity becomes
key to understanding its function. Since sequencing analysis
indicated that a subset of transcripts were dependent on RAM
for expression, this suggests that RAM does have sequence,
motif, or chromatin context specificity.
RAM Expression Control
The kinase ERK1/2 is upregulated during differentiation and
is an established suppressor of pluripotency-associated genesCell Reports 16, 1352–1365, August 2, 2016 1361
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Figure 7. High Levels of RNMT-RAM Are Required for Pluripotency
(A) Murine ESC, MEFs, and iPSCs were AP stained. Scale bar, 200 mm.
(B) Proteins analyzed by WB.
(C) Proteins analyzed by WB in extracts from human ESCs (hESC), human fibroblasts (hF), and human iPSCs (hiPS).
(D and E) Average transcript level for three independent experiments detected by RT-PCR in murine ESCs, MEFs, and iPSCs (D) and hESCs, hFs, and iPSCs (E).
(F) Oct4, Klf4, Sox2, and c-Myc expressed in MEFs and transcript levels detected on the days indicated.
(G and H) After 3–4 days, cells were also transfected with vectors to express RAM-GFP, or RAM-GFP and HA-RNMT (G) or cells were transfected with RNMT or
RAM siRNA (H). After 14 days, the relative number of colonies with ESC-like morphology and AP-positive colonies was scored. Mean and SD for three inde-
pendent experiments are shown. t test p values calculated relative to control (*p% 0.05). Representative wells of AP-stained iPSC colonies.(Burdon et al., 1999; Hamilton and Brickman, 2014; Stavridis
et al., 2007). ERK1/2 phosphorylates RAM S36, triggering
ubiquitination and proteosomal degradation. Phospho-S361362 Cell Reports 16, 1352–1365, August 2, 2016may recruit an E2/E3 ligase that ubiquitinates RAM or inhibits
interaction with a deubiquitinating enzyme. Our findings are
consistent with ERK1/2-dependent repression of RAM being
an important contributor to the mechanism by which it represses
pluripotency-associated genes (Burdon et al., 1999).
ERK1/2 specifically targets RAM for degradation, leaving
RNMT intact. RNMT and RAM interact with high affinity, and
RAM monomers are not readily observed in cells, and therefore,
the specific targeting of RAM is mechanistically surprising. How-
ever, our in vitro kinase assays revealed that ERK2 only phos-
phorylates monomeric RAM and not RAM in complex with
RNMT. In the RNMT-RAM structure, RAM S36 is partially buried
in RNMT and therefore inaccessible as an ERK1/2 substrate (un-
published data). Thus, ERK1/2 is able to specifically target newly
synthesized monomeric RAM for degradation, leaving existing
RNMT-RAM and nascent RNMT monomers intact.
RAM-ESC Gene Regulatory Network Feedback Provides
Robustness to Pluripotency
Here,wedescribe apositive feedback loopbetweenRNMT-RAM
and pluripotency-associated gene expression, which we postu-
late provides robustness to pluripotency and differentiation.
High levels of RAM result in the expression of a large cohort of
pluripotency associated genes. Should pluripotency-associated
transcript levels fluctuate in ESCs, high levels of RNMT-RAMwill
maintain their expression. However, when the trigger for differen-
tiation is sustained, these transcripts may fall below a threshold
at which RNMT-RAM cannot maintain their expression. At this
point, ERK1/2 activity increases, RAMbecomesphosphorylated,
ubiquitinated, anddegraded, andRAM-dependent pluripotency-
associated genes are repressed, permitting differentiation. Thus,
RNMT-RAM is a critical component of the pluripotency network.
EXPERIMENTAL PROCEDURES
ESC Culture
46C ESCs (expressing Sox1-GFP) derived from strain 129Ola mice were
cultured on 0.1% gelatin-coated dishes in Glasgow minimal essential medium
(Sigma), 10% knockout serum replacement, 1% modified Eagle’s medium
(MEM) non-essential amino acids, 1 mM sodium pyruvate (Life Technologies),
0.1 mM 2-mercaptoethanol (Sigma), and 100 U/ml recombinant human leuke-
mia inhibitory factor). hiPS4 and SA181 human ESC lines purchased from Cel-
lartis and maintained in DEF-CS (Cellartis). Human neural differentiation was
performed as described previously (Chambers et al., 2009), except that cells
were seeded at a density of 6 3 104 cells/cm2 on Matrigel (20 mg/cm2) and
grown for 48 hrs in cell medium before switching to differentiation media.
Murine neural differentiation was performed as described previously (Stavridis
et al., 2007; Ying et al., 2003). 0.5–1.5 3 104/cm2 ESCs were plated on 0.1%
gelatin-coated dishes in N2B27 (DMEM/F12; Gibco) supplemented with modi-
fied N2 (25 mg/ml insulin, 100 mg/ml apo-transferrin, 6 ng/ml progesterone,
16 mg/ml putrescine, 30 nM sodium selenite and 50 mg/ml BSA fraction V;
Gibco). Medium was renewed every 2 days.
Primary Neural Cell Culture
Primary cortical neurons established from E16 mice (strain C57Bl) are a mixed
population of terminally differentiated neurons from the cortex. Primary
neuronal cells were plated onto 10 mg/ml poly-L-lysine-coated flasks and
maintained in Neurobasal medium with B27 supplement (Life Technologies),
2 mM glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin (Lonza). As-
trocytes are dividing cells of the astroglial line, established from P2. Astrocytes
were maintained in DMEM/10% fetal calf serum until confluent.
Transfections
1 3 105 cells transfected with 200 pmol siRNA or non-targeting controls
(siGenome, Dharmacon) using Lipofectamine 2000 (Invitrogen). 1 3 106ESCs in a 10-cm dish transfected with 4 mg pPyPCAGIP plasmids using
Fugene HD (Promega) or Lipofectamine 2000 (Life Technologies). 1 mg/ml
puromycin was used for selection.
Reprogramming
1.5 3 105 MEFs were plated on a six-well plate well. 1.5 mg PB-TAP IRI
2OKSMimO (expressing Oct4, Klf4, Sox2, c-Myc), AG-rtTA (reverse tetracy-
cline transactivator), and HyPBase (transposase) was transfected using
Fugene HD (Invitrogen) (Kaji et al., 2009; Woltjen et al., 2009). At day 3 or 4,
cells were transfected with 200 pmol RAM siRNA, 1 mg pPyPCAGIP RAM-
GFP, or 0.5 mg pPyPCAGIP RAM-GFP and 0.5 mg pPyPCAGIP HA-RNMT.
Induced pluripotent cell colony number was counted following AP staining
after 14 days of reprogramming.
Statistics
Statistical methodologies are reported in figure legends and in proteomics and
RNA-seq experimental procedures.
See Supplemental Experimental Procedures for polysome profile and
RNA-seq analysis, proteomics analysis, molecular biology, immunological
techniques, kinase assay, and description of expression construct.
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